5 Spam-Free Article(s) Found
Sort:
Date
Filter:
7d
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Apple, American Express, Kraft Heinz and Teva Pharmaceutical http://www.zacks.com/stock/news/516895/the-zacks-analyst-blog-highlights-berkshire-hathaway-apple-american-express-kraft-heinz-and-teva-pharmaceutical?cid=CS-ZC-FT-press_releases-516895 Sep 13, 2019 - The Zacks Analyst Blog Highlights: Berkshire Hathaway, Apple, American Express, Kraft Heinz and Teva Pharmaceutical
Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal http://feeds.benzinga.com/~r/benzinga/~3/6bq5pVqC7OA/teva-dips-into-medical-marijuana-market-with-canndoc-distribution-deal Sep 13, 2019 -

Cannabis companies have been feverishly stitching up partnerships with each other, beverage companies and biopharma companies to tap into the market's huge potential.

Israel-based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has taken a giant leap of faith in this direction.

read more

Here Are the Last 3 Stocks I Bought -- and Why https://www.fool.com/investing/2019/09/12/here-are-the-last-3-stocks-i-bought-and-why.aspx?source=iedfolrf0000001 Sep 12, 2019 - Recent market volatility has created some compelling buying opportunities.
Novartis Announces Positive Long-Term Data on Migraine Drug http://www.zacks.com/stock/news/509529/novartis-announces-positive-long-term-data-on-migraine-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-509529 Sep 09, 2019 - Novartis' (NVS) migraine drug Aimovig is effective and safe in treating patients with episodic migraine in a long-term study.
Here's Why Teva Pharmaceuticals Dropped 13% in August https://www.fool.com/investing/2019/09/08/heres-why-teva-pharmaceuticals-dropped-13-in-augus.aspx?source=iedfolrf0000001 Sep 08, 2019 - Investors continued to back away from the troubled generic-drug company as lawsuits from the opioid crisis began to conclude.

Pages: 1

Page 1